BioSpace News Archive

Business

Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla™ Oncotype DX® Genomic Prostate Score® Test

Genomic Health, Inc. and Biocartis Group NV today announced they have expanded their exclusive collaboration into the field of urology with the development of an in vitro diagnostic (IVD) version of the Oncotype DX® Genomic Prostate Score® (GPS™) test on Biocartis’ Idylla™ platform and potentially additional cancer tests that can be performed locally by laboratory partners and in hospitals around the world.

December 3, 2018
·
8 min read
Drug Development

Verastem Oncology Announces Presentation of Updated Duvelisib Combination Clinical Data in Peripheral T-Cell Lymphoma at the American Society of Hematology 2018 Annual Meeting

Combination of Duvelisib and Romidepsin Resulting in a 59% Overall Response Rate in Relapsed or Refractory Peripheral T-Cell Lymphoma

December 3, 2018
·
9 min read
Pharm Country

Heart failure telemedicine programs prove effective 6 months after discharge, study finds

Home telemedicine programs for heart failure are effective at preventing death for at least six months after hospitalization, but generally lose any benefit after one year, according to a meta-analysis of clinical trials published today and announced tomorrow at a briefing.

December 3, 2018
·
3 min read
Deals

DionyMed Brands Inc. Began Trading November 28 and Provides Operational Update

DionyMed Brands Inc. is providing an operational update following the commencement of trading of the Company’s shares on the Canadian Securities Exchange on November 28, 2018.

December 3, 2018
·
5 min read
Biotech Bay

Varian Schedules 2019 Annual Stockholder Meeting in Palo Alto

Varian today announced that its Board of Directors has scheduled the 2019 Annual Meeting of Stockholders for February 14, 2019 with a record date of December 17, 2018.

December 3, 2018
·
1 min read
BioMidwest

Heartland Dental Hosts Supported Dentists and Dental Assistants for First-Annual Implant Continuum

The Company helps supported dental professionals advance their skills in dental implants

December 3, 2018
·
2 min read
Drug Development

Amgen Announces First-In-Human Data Evaluating Investigational Novel BiTE® Immunotherapies AMG 420 And AMG 330 At ASH 2018

Phase 1 Results of Amgen’s BiTE® Platform in Heavily Pre-Treated Patients With Multiple Myeloma and Acute Myeloid Leukemia

December 3, 2018
·
13 min read
Drug Development

Seattle Genetics and Takeda Present Positive Data from Phase 3 ECHELON-2 Clinical Trial for ADCETRIS® (Brentuximab Vedotin) in Frontline Treatment of CD30-Expressing Peripheral T-Cell Lymphomas

-Data Presented in Oral Session with Simultaneous Publication in The Lancet-

December 3, 2018
·
28 min read
Drug Development

Aruvant Sciences Presents Data from Ongoing Clinical Study of Lentiviral Gene Therapy RVT-1801 for Sickle Cell Disease at 60th Annual Meeting of the American Society of Hematology

Two patients have been administered RVT-1801 in conjunction with reduced intensity conditioning regimens

December 3, 2018
·
5 min read
Drug Development

Nordic Nanovector: Additional Preclinical Studies With CD37-targeting Radioimmunotherapies for B-cell Malignancies Presented at ASH

Nordic Nanovector ASA notes that two new poster presentations from preclinical studies with CD37-targeting radioimmunotherapies were made at the 60th American Society of Hematology (ASH) Annual Meeting & Exposition (1-4 December 2018 in San Diego, CA, USA).

December 3, 2018
·
5 min read